| 3006 | 0: Pharmaceutical goods specified in note 4 to this chapter |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
$145,432,033.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-01 $162,870,734.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-02 $190,682,317.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-03 $224,744,739.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-04 $132,296,697.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-05 $194,692,719.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-06 $215,318,708.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-07 $185,889,546.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-08 $186,141,373.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-09 $168,309,169.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-10 $182,397,330.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-11 $253,411,960.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2009-12 $108,591,006.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-01 $171,974,297.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-02 $234,136,864.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-03 $177,327,637.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-04 $142,816,464.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-05 $169,647,184.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-06 $167,329,029.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-07 $167,276,365.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-08 $187,050,569.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-09 $205,489,667.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-10 $172,811,373.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-11 $198,771,973.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2010-12 $173,796,008.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-01 $150,402,361.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-02 $178,527,559.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-03 $193,238,674.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-04 $193,298,677.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-05 $192,929,698.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-06 $172,508,484.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-07 $176,599,924.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-08 $218,882,752.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-09 $180,464,166.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-10 $160,282,540.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-11 $169,188,133.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2011-12 $208,324,572.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-01 $158,069,608.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-02 $184,327,957.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-03 $168,588,132.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-04 $201,409,467.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-05 $186,300,320.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-06 $170,053,443.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-07 $172,426,034.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-08 $174,696,711.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-09 $164,718,845.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-10 $234,120,340.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-11 $173,804,685.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2012-12 $139,324,190.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2013-01 $181,134,650.00 of HTS Code 3006 — pharmaceutical products imported by the US in 2013-02
| Top 10 suppliers | |
|---|---|
| Germany | $2,427,281,023 |
| Finland | $1,132,825,326 |
| China | $774,823,617 |
| Switzerland | $731,091,769 |
| Netherlands | $702,416,505 |
| Subscribers only | $671,569,325 |
| Subscribers only | $491,557,510 |
| United Kingdom | $398,199,951 |
| Subscribers only | $302,406,842 |
| Subscribers only | $226,268,225 |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
Germany exported $2,427,281,023.00 of HTS Code 3006 — pharmaceutical products to the US. Finland exported $1,132,825,326.00 of HTS Code 3006 — pharmaceutical products to the US. China exported $774,823,617.00 of HTS Code 3006 — pharmaceutical products to the US. Switzerland exported $731,091,769.00 of HTS Code 3006 — pharmaceutical products to the US. Netherlands exported $702,416,505.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $671,569,325.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $491,557,510.00 of HTS Code 3006 — pharmaceutical products to the US. United Kingdom exported $398,199,951.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $302,406,842.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $226,268,225.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $187,017,627.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $152,877,710.00 of HTS Code 3006 — pharmaceutical products to the US. Norway exported $152,821,567.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $151,885,091.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $150,991,683.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $101,112,964.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $71,896,679.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $42,473,012.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $29,224,303.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $26,987,616.00 of HTS Code 3006 — pharmaceutical products to the US. Brazil exported $26,449,844.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $25,824,116.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $13,974,015.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $11,987,425.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $6,052,933.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $4,445,960.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,174,043.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,397,433.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $731,757.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $642,770.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $551,668.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $520,340.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $364,358.00 of HTS Code 3006 — pharmaceutical products to the US. Luxembourg exported $272,863.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $262,039.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $261,088.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $237,512.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $206,922.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $128,752.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $93,324.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $81,011.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $76,009.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $48,823.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $48,481.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $44,641.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $44,055.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $39,739.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $33,108.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $29,846.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $17,299.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $14,161.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $10,944.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,954.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $6,641.00 of HTS Code 3006 — pharmaceutical products to the US. Singapore exported $6,050.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $6,026.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,053.00 of HTS Code 3006 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,335.00 of HTS Code 3006 — pharmaceutical products to the US.
| Subscribers only | 7.1% |
| Subscribers only | 0.9% |
| Subscribers only | 0.7% |
| Subscribers only | 0.7% |
| Subscribers only | 0.3% |
| Subscribers only | 0.3% |
| Subscribers only | 0.3% |
| Liechtenstein | 0.1% |
| Sweden | 0.1% |
| Mexico | 0.1% |
| Subscribers only | -5.0% |
| Subscribers only | -2.7% |
| Subscribers only | -0.9% |
| Subscribers only | -0.8% |
| Subscribers only | -0.6% |
| Subscribers only | -0.3% |
| Subscribers only | -0.2% |
| Belgium | -0.1% |
| Switzerland | -0.1% |
| Hungary | -0.1% |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3006 — - to the US by 7.096%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3006 — - to the US by 0.882%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3006 — - to the US by 0.710%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3006 — - to the US by 0.651%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3006 — - to the US by 0.338%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3006 — - to the US by 0.310%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3006 — - to the US by 0.273%.
Liechtenstein increased in shipments of HTS Code 3006 — - to the US by 0.117%.
Sweden increased in shipments of HTS Code 3006 — - to the US by 0.116%.
Mexico increased in shipments of HTS Code 3006 — - to the US by 0.094%.
Hungary decreased in shipments of HTS Code 3006 — - to the US by -0.076%.
Switzerland decreased in shipments of HTS Code 3006 — - to the US by -0.112%.
Belgium decreased in shipments of HTS Code 3006 — - to the US by -0.123%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3006 — - to the US by -0.227%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3006 — - to the US by -0.252%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3006 — - to the US by -0.553%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3006 — - to the US by -0.816%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3006 — - to the US by -0.868%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3006 — - to the US by -2.713%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3006 — - to the US by -4.989%.
| 2009 | 2010 | 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| * | País | Share | Trend | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All |
100%
|
145,432 | 162,871 | 190,682 | 224,745 | 132,297 | 194,693 | 215,319 | 185,890 | 186,141 | 168,309 | 182,397 | 253,412 | 108,591 | 171,974 | 234,137 | 177,328 | 142,816 | 169,647 | 167,329 | 167,276 | 187,051 | 205,490 | 172,811 | 198,772 | 173,796 | 150,402 | 178,528 | 193,239 | 193,299 | 192,930 | 172,508 | 176,600 | 218,883 | 180,464 | 160,283 | 169,188 | 208,325 | 158,070 | 184,328 | 168,588 | 201,409 | 186,300 | 170,053 | 172,426 | 174,697 | 164,719 | 234,120 | 173,805 | 139,324 | 181,135 | ||||
| 1. | Germany |
27%
|
62,636 | 58,630 | 84,962 | 97,725 | 34,326 | 79,511 | 88,983 | 39,658 | 85,211 | 49,302 | 84,544 | 121,275 | 33,540 | 37,704 | 69,277 | 52,309 | 33,196 | 50,309 | 49,100 | 39,594 | 56,187 | 55,108 | 43,287 | 46,206 | 42,965 | 30,925 | 27,953 | 45,713 | 43,291 | 38,463 | 32,189 | 38,226 | 36,830 | 49,199 | 41,597 | 38,011 | 31,712 | 41,417 | 40,370 | 36,387 | 29,111 | 32,269 | 47,064 | 33,223 | 34,847 | 33,305 | 47,331 | 41,942 | 27,190 | 33,175 | |||
| 2. | Finland |
13%
|
11,731 | 5,977 | 24,204 | 18,322 | 29,090 | 23,302 | 20,191 | 20,666 | 14,219 | 14,185 | 13,247 | 35,867 | 7,390 | 20,570 | 35,973 | 22,033 | 26,523 | 12,931 | 20,228 | 6,436 | 21,788 | 14,233 | 13,949 | 28,399 | 29,545 | 28,919 | 21,800 | 28,651 | 21,995 | 35,941 | 14,803 | 21,892 | 36,347 | 14,468 | 0 | 7,462 | 21,834 | 7,662 | 28,637 | 36,831 | 81,428 | 22,279 | 37,067 | 22,214 | 21,982 | 14,190 | 37,715 | 28,480 | 21,314 | 27,919 | |||
| 3. | China |
9%
|
9,091 | 11,581 | 17,000 | 16,830 | 18,018 | 16,249 | 15,937 | 19,641 | 12,128 | 20,847 | 14,529 | 25,571 | 8,995 | 17,996 | 19,049 | 18,871 | 7,617 | 22,888 | 15,148 | 19,983 | 18,696 | 17,355 | 13,683 | 18,978 | 12,080 | 8,092 | 22,242 | 11,396 | 18,049 | 22,226 | 14,868 | 20,886 | 10,929 | 11,958 | 13,940 | 9,984 | 18,542 | 8,550 | 14,763 | 12,374 | 12,788 | 15,780 | 11,060 | 15,786 | 9,552 | 17,640 | 14,480 | 16,204 | 17,076 | 16,897 | |||
| 4. | Switzerland |
8%
|
3,187 | 12,277 | 10,457 | 14,027 | 11,382 | 11,978 | 14,418 | 15,177 | 13,280 | 11,999 | 3,767 | 11,731 | 11,978 | 16,306 | 15,931 | 14,328 | 11,975 | 19,319 | 10,965 | 11,405 | 16,892 | 13,654 | 23,394 | 8,033 | 13,340 | 15,683 | 19,471 | 16,030 | 20,860 | 13,836 | 21,289 | 11,837 | 12,509 | 17,074 | 19,978 | 20,227 | 13,484 | 14,051 | 19,081 | 16,685 | 12,491 | 19,948 | 14,501 | 14,114 | 15,213 | 20,392 | 17,523 | 13,950 | 12,381 | 17,281 | |||
| 5. | Netherlands |
8%
|
2,263 | 17,712 | 6,267 | 21,386 | 95 | 9,353 | 16,422 | 34,149 | 10,945 | 11,146 | 11,365 | 336 | 5,959 | 18,811 | 24,709 | 5,866 | 5,898 | 5,497 | 5 | 30,158 | 10 | 26,555 | 10,238 | 17,840 | 9,784 | 12,372 | 18,791 | 22,187 | 18,621 | 13,639 | 18,182 | 8,928 | 51,629 | 8,948 | 10,322 | 11,934 | 45,402 | 21,628 | 2,192 | 23 | 32 | 7,835 | 643 | 12,121 | 35,351 | 11,637 | 35,437 | 2,662 | 11,818 | 17,310 | |||
| 6. | Subscribers only |
7%
|
13,859 | 11,444 | 7,635 | 6,876 | 7,727 | 7,329 | 15,173 | 9,404 | 1,232 | 8,450 | 14,328 | 14,109 | 7,864 | 14,192 | 9,099 | 12,559 | 10,005 | 8,946 | 11,531 | 8,667 | 12,636 | 23,209 | 10,088 | 14,115 | 11,806 | 8,831 | 18,480 | 16,982 | 22,248 | 15,159 | 24,126 | 12,185 | 19,805 | 18,018 | 24,161 | 31,921 | 10,377 | 13,598 | 13,987 | 14,892 | 14,052 | 11,194 | 12,172 | 13,529 | 7,594 | 13,801 | 22,724 | 17,996 | 8,388 | 13,067 | |||
| 7. | Subscribers only |
5%
|
11,397 | 12,760 | 7,356 | 12,662 | 5,766 | 5,050 | 9,198 | 8,599 | 9,784 | 13,714 | 6,086 | 3,934 | 6,516 | 8,826 | 14,556 | 15,223 | 10,154 | 11,652 | 10,179 | 10,425 | 17,791 | 9,382 | 9,709 | 25,117 | 14,294 | 6,734 | 6,434 | 5,206 | 5,850 | 7,164 | 6,363 | 12,560 | 5,748 | 14,156 | 6,277 | 11,868 | 15,990 | 7,624 | 9,221 | 7,487 | 7,367 | 17,276 | 7,222 | 16,034 | 7,929 | 7,123 | 6,380 | 9,027 | 6,715 | 7,673 | |||
| 8. | United Kingdom |
4%
|
7,409 | 6,954 | 8,637 | 8,093 | 4,695 | 9,113 | 6,083 | 10,030 | 7,658 | 5,660 | 6,372 | 8,721 | 6,080 | 11,950 | 11,121 | 8,542 | 8,619 | 6,378 | 13,093 | 6,829 | 10,855 | 12,447 | 8,502 | 9,648 | 8,197 | 9,075 | 8,334 | 7,030 | 8,126 | 9,845 | 7,978 | 8,753 | 9,731 | 9,519 | 5,863 | 9,778 | 8,768 | 5,485 | 4,216 | 3,505 | 6,628 | 4,839 | 7,364 | 8,023 | 7,863 | 7,996 | 5,759 | 7,254 | 7,135 | 7,644 | |||
| 9. | Subscribers only |
3%
|
6,322 | 2,404 | 4,375 | 5,191 | 2,369 | 5,354 | 7,677 | 7,431 | 3,727 | 5,617 | 5,239 | 5,457 | 2,340 | 4,205 | 6,593 | 2,953 | 7,639 | 3,994 | 8,975 | 6,809 | 5,551 | 7,693 | 3,334 | 5,906 | 5,953 | 4,802 | 6,398 | 12,585 | 7,248 | 6,476 | 7,305 | 11,105 | 6,746 | 6,506 | 7,630 | 3,328 | 7,339 | 6,568 | 6,513 | 7,225 | 4,515 | 8,275 | 5,943 | 8,439 | 4,227 | 6,035 | 10,621 | 2,962 | 5,660 | 4,850 | |||
| 10. | Subscribers only |
3%
|
2,879 | 2,999 | 2,223 | 3,556 | 2,177 | 4,959 | 3,988 | 5,146 | 5,059 | 4,602 | 4,526 | 4,696 | 2,699 | 2,977 | 3,778 | 4,172 | 3,110 | 4,995 | 4,162 | 4,785 | 3,618 | 6,102 | 4,847 | 3,497 | 5,178 | 5,664 | 4,532 | 4,695 | 5,596 | 5,793 | 5,668 | 5,045 | 4,931 | 4,237 | 3,515 | 3,181 | 3,926 | 5,849 | 3,955 | 4,365 | 5,500 | 4,328 | 5,538 | 5,930 | 6,192 | 6,160 | 6,055 | 4,706 | 4,454 | 5,724 | |||
| 11. | Subscribers only |
2%
|
2,824 | 4,090 | 3,505 | 3,464 | 2,305 | 4,225 | 2,876 | 3,088 | 3,422 | 3,767 | 4,238 | 3,797 | 1,612 | 5,113 | 3,654 | 2,283 | 1,894 | 4,405 | 3,553 | 1,636 | 3,805 | 4,035 | 5,694 | 2,452 | 2,583 | 2,678 | 3,507 | 2,933 | 3,935 | 3,773 | 2,046 | 4,106 | 3,262 | 3,061 | 4,566 | 4,235 | 3,927 | 4,171 | 4,034 | 3,677 | 4,304 | 2,488 | 4,461 | 2,003 | 5,360 | 7,043 | 6,550 | 6,362 | 2,000 | 8,215 | |||
| 12. | Subscribers only |
2%
|
554 | 1,534 | 1,814 | 1,822 | 1,544 | 2,942 | 22 | 501 | 4,193 | 3,695 | 1,728 | 3,623 | 1,538 | 11 | 3,025 | 4,410 | 1,172 | 3,327 | 2,336 | 5,366 | 2,673 | 903 | 5,960 | 3,061 | 3 | 1,632 | 2,131 | 8 | 2,842 | 3,327 | 722 | 4,415 | 3,286 | 6,623 | 6,487 | 2,262 | 10,360 | 6,170 | 12,799 | 10,359 | 4,598 | 11,940 | 4 | 43 | 0 | 11 | 3 | 6 | 42 | 5,055 | |||
| 13. | Norway |
2%
|
3,494 | 5,016 | 2,778 | 4,287 | 2,871 | 3,286 | 2,501 | 2,023 | 2,873 | 3,435 | 2,300 | 578 | 3,099 | 2,423 | 3,408 | 2,583 | 3,521 | 2,660 | 5,216 | 865 | 2,853 | 2,998 | 5,290 | 6,449 | 3,993 | 2,852 | 5,158 | 4,158 | 2,851 | 4,416 | 3,904 | 1,811 | 3,444 | 2,253 | 3,002 | 2,266 | 2,668 | 1,803 | 2,395 | 1,933 | 2,166 | 3,912 | 3,080 | 1,695 | 2,871 | 3,745 | 4,578 | 2,868 | 1,196 | 995 | |||
| 14. | Subscribers only |
2%
|
2,135 | 1,411 | 2,230 | 2,297 | 2,438 | 2,481 | 2,063 | 2,404 | 3,895 | 2,564 | 2,426 | 3,572 | 3,486 | 3,099 | 3,400 | 1,792 | 2,183 | 1,620 | 2,288 | 2,575 | 2,654 | 1,647 | 1,900 | 2,417 | 3,707 | 3,195 | 4,472 | 6,123 | 3,103 | 3,478 | 3,129 | 5,443 | 3,228 | 2,568 | 3,225 | 3,137 | 2,687 | 2,297 | 5,386 | 2,357 | 5,894 | 5,021 | 2,677 | 4,023 | 3,643 | 2,775 | 3,322 | 2,082 | 3,260 | 2,678 | |||
| 15. | Subscribers only |
2%
|
744 | 2,005 | 2,149 | 2,069 | 1,584 | 2,081 | 3,357 | 2,096 | 2,683 | 3,677 | 2,022 | 3,211 | 263 | 1,451 | 3,374 | 2,975 | 3,271 | 3,134 | 4,155 | 3,685 | 4,017 | 3,237 | 5,025 | 1,826 | 3,016 | 2,278 | 3,088 | 2,243 | 2,643 | 2,508 | 3,599 | 2,734 | 3,762 | 5,512 | 2,609 | 3,062 | 2,799 | 3,751 | 3,640 | 3,991 | 3,519 | 4,477 | 3,346 | 3,969 | 4,738 | 4,221 | 3,365 | 3,544 | 1,561 | 2,925 | |||
| 16. | Subscribers only |
1%
|
1,894 | 1,957 | 2,471 | 2,358 | 2,443 | 2,665 | 2,756 | 2,215 | 2,563 | 1,955 | 1,670 | 2,547 | 2,142 | 2,673 | 2,942 | 2,533 | 2,852 | 3,055 | 2,711 | 3,003 | 3,074 | 2,474 | 2,765 | 1,169 | 1,347 | 1,474 | 1,365 | 1,562 | 1,796 | 1,430 | 1,518 | 1,983 | 1,999 | 1,669 | 1,612 | 1,146 | 1,360 | 1,473 | 1,987 | 1,475 | 2,199 | 1,878 | 2,030 | 1,487 | 1,372 | 1,481 | 2,001 | 1,445 | 1,517 | 1,621 | |||
| 17. | Subscribers only |
1%
|
802 | 1,923 | 748 | 869 | 1,259 | 1,492 | 1,085 | 1,514 | 1,339 | 966 | 1,613 | 1,460 | 511 | 1,413 | 1,247 | 1,348 | 1,273 | 1,765 | 1,028 | 1,423 | 1,160 | 1,123 | 1,493 | 1,104 | 2,064 | 967 | 1,458 | 1,373 | 1,679 | 1,277 | 1,218 | 1,608 | 1,349 | 1,691 | 1,351 | 1,387 | 1,746 | 2,270 | 1,507 | 1,482 | 1,757 | 1,505 | 1,850 | 1,443 | 1,615 | 2,108 | 1,668 | 1,762 | 1,541 | 2,261 | |||
| 18. | Subscribers only |
<1%
|
191 | 223 | 73 | 302 | 67 | 87 | 98 | 129 | 85 | 152 | 120 | 201 | 162 | 45 | 119 | 653 | 81 | 990 | 830 | 705 | 571 | 892 | 1,368 | 26 | 623 | 864 | 253 | 849 | 174 | 422 | 736 | 258 | 906 | 196 | 424 | 59 | 2,679 | 47 | 6,616 | 446 | 250 | 3,121 | 1,341 | 1,669 | 1,144 | 714 | 2,341 | 4,705 | 470 | 2,997 | |||
| 19. | Subscribers only |
<1%
|
161 | 426 | 117 | 333 | 310 | 337 | 273 | 238 | 261 | 244 | 518 | 752 | 519 | 740 | 703 | 345 | 251 | 158 | 262 | 720 | 538 | 224 | 295 | 803 | 930 | 1,417 | 504 | 1,216 | 524 | 617 | 526 | 407 | 376 | 661 | 1,364 | 719 | 446 | 426 | 431 | 694 | 157 | 4,910 | 594 | 768 | 556 | 180 | 510 | 218 | 266 | 278 | |||
| 20. | Subscribers only |
<1%
|
399 | 422 | 309 | 409 | 570 | 570 | 445 | 577 | 486 | 410 | 242 | 413 | 457 | 508 | 344 | 340 | 445 | 495 | 534 | 477 | 449 | 543 | 366 | 398 | 471 | 727 | 680 | 628 | 567 | 672 | 587 | 725 | 487 | 745 | 857 | 632 | 739 | 641 | 781 | 597 | 767 | 538 | 710 | 651 | 774 | 610 | 643 | 456 | 548 | 148 | |||
| 21. | Brazil |
<1%
|
860 | 249 | 664 | 752 | 594 | 613 | 780 | 607 | 661 | 628 | 554 | 790 | 676 | 418 | 422 | 646 | 628 | 570 | 432 | 476 | 490 | 223 | 790 | 417 | 366 | 459 | 503 | 706 | 367 | 654 | 533 | 655 | 669 | 378 | 512 | 311 | 323 | 546 | 536 | 486 | 300 | 242 | 415 | 821 | 512 | 696 | 633 | 380 | 295 | 212 | |||
| 22. | Subscribers only |
<1%
|
183 | 218 | 73 | 126 | 133 | 180 | 13 | 28 | 43 | 179 | 82 | 87 | 72 | 102 | 80 | 9 | 36 | 56 | 11 | 5 | 7 | 41 | 50 | 13 | 357 | 0 | 0 | 423 | 183 | 492 | 27 | 38 | 367 | 10 | 266 | 1,565 | 185 | 672 | 592 | 554 | 624 | 1,242 | 71 | 3,523 | 747 | 1,841 | 1,369 | 3,910 | 3,600 | 1,338 | |||
| 23. | Subscribers only |
<1%
|
238 | 350 | 232 | 252 | 224 | 342 | 152 | 250 | 158 | 304 | 540 | 332 | 286 | 155 | 449 | 203 | 176 | 232 | 325 | 198 | 426 | 686 | 429 | 360 | 74 | 256 | 219 | 108 | 225 | 332 | 494 | 127 | 205 | 187 | 436 | 255 | 333 | 199 | 346 | 220 | 348 | 255 | 211 | 320 | 232 | 296 | 290 | 142 | 245 | 318 | |||
| 24. | Subscribers only |
<1%
|
116 | 216 | 192 | 288 | 153 | 213 | 204 | 165 | 119 | 311 | 218 | 273 | 309 | 232 | 175 | 147 | 172 | 181 | 236 | 238 | 152 | 278 | 150 | 322 | 203 | 194 | 305 | 310 | 177 | 200 | 310 | 335 | 203 | 293 | 130 | 315 | 267 | 97 | 217 | 288 | 435 | 242 | 420 | 108 | 265 | 197 | 378 | 219 | 415 | 406 | |||
| 25. | Subscribers only |
<1%
|
8 | 0 | 27 | 5 | 7 | 16 | 61 | 12 | 3 | 26 | 17 | 11 | 17 | 33 | 6 | 21 | 21 | 17 | 0 | 6 | 4 | 57 | 4 | 8 | 22 | 30 | 37 | 73 | 141 | 219 | 262 | 48 | 51 | 48 | 80 | 100 | 225 | 297 | 36 | 45 | 109 | 484 | 62 | 457 | 46 | 334 | 2,316 | 23 | 43 | 78 | |||
| 26. | Subscribers only |
<1%
|
0 | 0 | 65 | 386 | 0 | 165 | 420 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 420 | 6 | 0 | 0 | 0 | 425 | 0 | 404 | 0 | 27 | 417 | 0 | 423 | 0 | 424 | 0 | 0 | 0 | 420 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 412 | 7 | 0 | |||
| 27. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 722 | 0 | 0 | 0 | 402 | 0 | 49 | 30 | 0 | 10 | 0 | 0 | 0 | 0 | 196 | 0 | 0 | 0 | 175 | 444 | 145 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 28. | Subscribers only |
<1%
|
32 | 20 | 24 | 17 | 10 | 10 | 36 | 26 | 0 | 36 | 51 | 0 | 22 | 13 | 8 | 56 | 45 | 36 | 22 | 25 | 60 | 20 | 58 | 11 | 27 | 46 | 2 | 39 | 80 | 7 | 29 | 18 | 38 | 18 | 19 | 32 | 57 | 7 | 29 | 73 | 36 | 12 | 59 | 6 | 19 | 44 | 16 | 9 | 30 | 5 | |||
| 29. | Subscribers only |
<1%
|
0 | 22 | 0 | 0 | 26 | 8 | 0 | 0 | 47 | 0 | 0 | 0 | 20 | 0 | 6 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 19 | 0 | 0 | 7 | 0 | 0 | 6 | 45 | 5 | 45 | 45 | 0 | 0 | 87 | 0 | 0 | 76 | 0 | 0 | 7 | 0 | 42 | 26 | 22 | 44 | 79 | 45 | |||
| 30. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 643 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 31. | Subscribers only |
<1%
|
21 | 10 | 36 | 30 | 33 | 24 | 34 | 39 | 32 | 0 | 38 | 0 | 6 | 0 | 3 | 9 | 11 | 7 | 4 | 7 | 58 | 3 | 55 | 0 | 0 | 6 | 0 | 5 | 25 | 3 | 29 | 3 | 0 | 0 | 0 | 0 | 10 | 0 | 5 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 32. | Subscribers only |
<1%
|
0 | 15 | 44 | 0 | 74 | 30 | 72 | 33 | 10 | 30 | 11 | 17 | 0 | 0 | 30 | 111 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | |||
| 33. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 360 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 34. | Luxembourg |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 273 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 35. | Subscribers only |
<1%
|
0 | 0 | 4 | 5 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 3 | 0 | 2 | 0 | 0 | 111 | 38 | 19 | 52 | 6 | |||
| 36. | Subscribers only |
<1%
|
0 | 0 | 2 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 58 | 0 | 17 | 25 | 35 | 60 | 12 | 0 | 0 | 25 | 7 | 0 | 0 | 0 | 0 | 0 | |||
| 37. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | 2 | 0 | 0 | 0 | 0 | 86 | 0 | 0 | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 38. | Subscribers only |
<1%
|
0 | 0 | 4 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 5 | 5 | 8 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 6 | 20 | 11 | 0 | 0 | 0 | 7 | 104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 39. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 129 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 40. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 32 | 0 | 0 | 0 | 0 | 2 | 0 | 16 | |||
| 41. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54 | 15 | 6 | 0 | |||
| 42. | Subscribers only |
<1%
|
0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 43. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 44. | Subscribers only |
<1%
|
0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 45. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 46. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 13 | 0 | 0 | 0 | 0 | 5 | 0 | 13 | 0 | 3 | 0 | 4 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | |||
| 47. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 48. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 49. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 50. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 4 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 51. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 52. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 53. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 54. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 55. | Singapore |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 56. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 57. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 58. | Subscribers only |
<1%
|
0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 59. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Import | Export | Descripción |
|---|---|---|
| 30 | 30 | Pharmaceutical products |
| 3001 | 3001 | 0: Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included |
| 3002 | 3002 | Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: |
| 3003 | 3003 | 0: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale |
| 3004 | 3004 | 0: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
| 3005 | 3005 | 0: Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes |
| 3006 | 3006 | 0: Pharmaceutical goods specified in note 4 to this chapter |
| 3006.10 | 3006.10 | Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical/dental yarns)&sterile tissue adhesives for surgical wound closure: sterile laminaria&sterile laminaria tents: sterile absorbable surgical/dental/veterinary pu |
| 3006.20 | 3006.20 | Blood-grouping reagents |
| 3006.30 | 3006.30 | Pharmaceutical products: Pharmaceutical goods specified in note 4 to this chapter |
| 3006.40 | 3006.40 | Dental cements & other dental fillings: bone reconstruction cements |
| 3006.50 | 3006.50 | First-aid boxes & kits |
| 3006.60 | 3006.60 | Chemical contraceptive preparations based on hormones/other products of 29.37/spermicides |
| 3006.70 | 3006.70 | Gel preparations designed to be used in human/veterinary medicine as a lubricant for parts of the body for surgical operations/physical examinations/as a coupling agent between the body & medical instruments |
| 3006.91 | 3006.91 | Appliances identifiable for ostomy use |
| 3006.92 | 3006.92 | Waste pharmaceuticals |